Addex Therapeutics Ltd.
ADXN나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
2건
최근 2026.10.29
90일 내부자 순매수
0원
변동 없음
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 14건
- US미국주요사항·수시공시중요도 낮음5일 전6-K · Report of foreign private issuer
Addex Therapeutics Ltd.ADXN
6-K · 2026.10.29 19:05 KST
- US미국주요사항·수시공시중요도 낮음2026.10.086-K · Report of foreign private issuer
Addex Therapeutics Ltd.ADXN
6-K · 2026.10.08 19:05 KST
- US미국주요사항·수시공시중요도 낮음2026.10.026-K · Report of foreign private issuer
Addex Therapeutics Ltd.ADXN
6-K · 2026.10.02 19:05 KST
- US미국주요사항·수시공시중요도 낮음2026.09.286-K · Report of foreign private issuer
Addex Therapeutics Ltd.ADXN
6-K · 2026.09.28 20:06 KST
- US미국주요사항·수시공시중요도 낮음2026.09.256-K · Report of foreign private issuer
Addex Therapeutics Ltd.ADXN
6-K · 2026.09.25 19:05 KST
- US미국대량보유(5%)중요도 보통2026.09.04정정SCHEDULE 13D/A · Beneficial ownership report (13D)
Addex Therapeutics Ltd.ADXN
SCHEDULE 13D/A · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Addex Therapeutics Ltd.ADXN
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Addex Therapeutics Ltd.ADXN
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Addex Therapeutics Ltd.ADXN
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Addex Therapeutics Ltd.ADXN
Form 4 · 2026.09.04